User profiles for "author:Suzanne McCarthy"

Suzanne McCarthy

University College Cork
Verified email at ucc.ie
Cited by 3851

[HTML][HTML] The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder

SV Faraone, T Banaschewski, D Coghill… - Neuroscience & …, 2021 - Elsevier
Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

[HTML][HTML] Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of …

L Hennissen, MJ Bakker, T Banaschewski, S Carucci… - CNS drugs, 2017 - Springer
Background Many children and adolescents with attention deficit/hyperactivity disorder
(ADHD) are treated with stimulant and non-stimulant medication. ADHD medication may be …

Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature

J Gallagher, S McCarthy, S Byrne - International journal of clinical …, 2014 - Springer
Background Clinical and cost-effectiveness evidence are needed to justify the existence or
extension of routine clinical pharmacy services in hospital settings. Previous reviews have …

[HTML][HTML] The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care

S McCarthy, L Wilton, ML Murray, P Hodgkins… - BMC pediatrics, 2012 - Springer
Abstract Background Attention Deficit Hyperactivity Disorder (ADHD) is a common
neurodevelopmental disorder characterised by the symptoms of inattention, impulsivity and …

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

S McCarthy, P Asherson, D Coghill, C Hollis… - The British Journal of …, 2009 - cambridge.org
BackgroundSymptoms of attention-deficit hyperactivity disorder (ADHD) are known to persist
into adulthood in the majority of cases. AimsTo determine the prevalence of …

Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using …

S McCarthy, N Cranswick, L Potts, E Taylor, ICK Wong - Drug safety, 2009 - Springer
Background: Following reports of sudden death in patients taking medication to treat
attention-deficit hyperactivity disorder (ADHD), this study aimed to identify cases of death in …

Association of risk of suicide attempts with methylphenidate treatment

KKC Man, D Coghill, EW Chan, WCY Lau… - JAMA …, 2017 - jamanetwork.com
Importance Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased
risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most …

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic …

KKC Man, A Häge, T Banaschewski, SK Inglis… - The Lancet …, 2023 - thelancet.com
Background Methylphenidate is the most frequently prescribed medication for the treatment
of ADHD in children and adolescents in many countries. Although many randomised …

[HTML][HTML] Cost-outcome description of clinical pharmacist interventions in a university teaching hospital

J Gallagher, S Byrne, N Woods, D Lynch… - BMC health services …, 2014 - Springer
Background Pharmacist interventions are one of the pivotal parts of a clinical pharmacy
service within a hospital. This study estimates the cost avoidance generated by pharmacist …

Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis

S Carucci, C Balia, A Gagliano, A Lampis… - Neuroscience & …, 2021 - Elsevier
Background Methylphenidate (MPH) is an efficacious treatment for ADHD but concerns have
been raised about potential adverse effects of extended treatment on growth. Objectives To …